Vaginal micronised progesterone soft gel capsule for the treatment of threatened miscarriage

Description

In this Product Explainer, Professor of Obstetrics & Gynaecology, William Ledger explains the role of vaginal micronised progesterone, including the indication, safety profile, clinical trial background and guidelines for use for the treatment and management of threatened miscarriage (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Sonia Grover

Prof Sonia Grover

Heavy Menstrual Bleeding in Adolescents

Clinical A/Prof Greg Katsoulotos

Clinical A/Prof Greg Katsoulotos

Chronic & Recurrent Cough – A Practical Approach

A/Prof Gary Leong

A/Prof Gary Leong

DKA Prevention & Diabetes in Children

A/Prof Lata Vadlamudi

A/Prof Lata Vadlamudi

Epilepsy & Menopause

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof William Ledger

expert

Prof William Ledger

Gynaecologist; Royal Hospital for Women, UNSW

Date published: 8 August 2023